ArticleJournal of the American Heart Association2020

Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation.

Andrew Xanthopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.